Patients with non-seasonal depression who were treated with bright light therapy reported a 40% remission rate, according to a recent study.

Patients with comorbid depression and insomnia do not feel satisfied by their health care providers or available treatment options.

For older adults at risk for cognitive decline, especially those with remitted major depressive disorder (rMDD) — with or ...

MindMed is poised for significant developments with MM-120 in upcoming trials. Discover why monitoring MNMD stock is ...

Approved in March 2019, esketamine is currently indicated for use alongside an oral antidepressant for treatment-resistant ...

During certain seasons of the year, you may notice changes in your energy level, sleep and interest in activities.

The observed inverse associations between iron, copper, and vitamin D with the risk of MDD and rMDD suggest that these ...

As daylight saving time ends, a psychiatric expert shares how to cope with the decrease in sunlight and the changes on the ...